109 related articles for article (PubMed ID: 12401263)
1. Thailand court forces reversal of drug firm antiretroviral patent.
Ahmad K
Lancet; 2002 Oct; 360(9341):1231. PubMed ID: 12401263
[No Abstract] [Full Text] [Related]
2. The role of civil society in protecting public health over commercial interests: lessons from Thailand.
Ford N; Wilson D; Bunjumnong O; von Schoen Angerer T
Lancet; 2004 Feb; 363(9408):560-3. PubMed ID: 14975620
[No Abstract] [Full Text] [Related]
3. Drug firms lose patent rights lawsuit against South Africa's government.
Baleta A
Lancet; 2001 Apr; 357(9265):1347. PubMed ID: 11343755
[No Abstract] [Full Text] [Related]
4. Global trade and access to medicines: AIDS treatments in Thailand.
Wilson D; Cawthorne P; Ford N; Aongsonwang S
Lancet; 1999 Nov; 354(9193):1893-5. PubMed ID: 10584741
[No Abstract] [Full Text] [Related]
5. Brazil and USA at loggerheads over production of generic antiretrovirals.
Ahmad K
Lancet; 2001 Feb; 357(9254):453. PubMed ID: 11273079
[No Abstract] [Full Text] [Related]
6. Pharmaceuticals and medical devices: business practices.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
[No Abstract] [Full Text] [Related]
7. Pharmaceuticals and medical devices: business practices. Issue brief.
Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448
[No Abstract] [Full Text] [Related]
8. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
Halliburton M
Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
[TBL] [Abstract][Full Text] [Related]
9. The Myth of the Free Market for Pharmaceuticals.
Conti RM; Frank RG; Cutler DM
N Engl J Med; 2024 Apr; 390(16):1448-1450. PubMed ID: 38647106
[No Abstract] [Full Text] [Related]
10. Thailand: successful challenge to invalid patent claim on antiretrovirals.
Kaplan K
Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):60-1. PubMed ID: 14740606
[TBL] [Abstract][Full Text] [Related]
11. Drug costs threaten patent protection.
Cimons M
Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
[No Abstract] [Full Text] [Related]
12. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
13. AIDS drugs. Brazil, Thailand override big pharma patents.
Cohen J
Science; 2007 May; 316(5826):816. PubMed ID: 17495145
[No Abstract] [Full Text] [Related]
14. Initiatives to challenge patent barriers and their relationship with the price of medicines procured by the Brazilian Unified National Health System.
Scopel CT; Chaves GC
Cad Saude Publica; 2016 Dec; 32(11):e00113815. PubMed ID: 27925025
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceuticals and medical devices: business practices.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
[No Abstract] [Full Text] [Related]
16. Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1.
Paton NI; Aboulhab J; Karim F
Lancet; 2002 May; 359(9318):1667-8. PubMed ID: 12020529
[TBL] [Abstract][Full Text] [Related]
17. Canada to change patent law to allow export of cheap drugs.
Kondro W
Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
[No Abstract] [Full Text] [Related]
18. Closing the affordability gap for drugs in low-income countries.
Steinbrook R
N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
[No Abstract] [Full Text] [Related]
19. US concedes on cheaper drug production in Brazil.
Gottlieb S
BMJ; 2001 Jul; 323(7303):12. PubMed ID: 11440934
[No Abstract] [Full Text] [Related]
20. Patenting ESTs: is it worth it?
Nat Genet; 1999 Feb; 21(2):145-6. PubMed ID: 9988257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
